Skip to Content

Abacavir

In the US, Abacavir (abacavir systemic) is a member of the drug class nucleoside reverse transcriptase inhibitors (NRTIs) and is used to treat HIV Infection and Nonoccupational Exposure.

US matches:

UK matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

J05AF06

CAS registry number (Chemical Abstracts Service)

0136470-78-5

Chemical Formula

C14-H18-N6-O

Molecular Weight

286

Therapeutic Categories

Antiviral agent

Nucleoside reverse transcriptase inhibitor (NRTI)

Treatment of HIV infection

Chemical Name

(1S,4R)-4-[2-Amino-6-(cyclopropylamino)-9H-purin-9-yl]-2-cyclopentene-1-metanol (WHO)

Foreign Names

  • Abacavirum (Latin)
  • Abacavir (German)
  • Abacavir (French)
  • Abacavir (Spanish)

Generic Names

  • Abacavir (OS: BAN, DCF)
  • Abacavir Sulfate (OS: USAN, BANM, JAN)
  • 1592 U 89 sulfate (IS: GlaxoWellcome)
  • Abacavir Sulfate (PH: BP 2015, USP 37)
  • Abacavir sulfate (PH: Ph. Eur. 8, Ph. Int. 4)
  • Abacavir, sulfate de (PH: Ph. Eur. 8)
  • Abacaviri sulfas (PH: Ph. Eur. 8, Ph. Int. 4)
  • Abacavirsulfat (PH: Ph. Eur. 8)

Brand Names

  • Abacavir
    Eske, Peru
  • Abacavir Elea
    Elea, Argentina
  • Abacavir Humax
    Humax Pharmaceutical, Colombia
  • Abacavir Sulfate
    Aurobindo, Kenya
  • Abacavir/Lamivudine/Zidovudine Teva (Abacavir and Lamivudine, + Zidovudine)
    Teva, Netherlands
  • Abamune
    Biotoscana, Colombia; Cipla, Georgia
  • Abavan
    OKASA, Peru; Vitalchem, Colombia
  • Abavir
    Cipla, Venezuela; Hetero, India
  • Abec
    Emcure, India
  • Albavir Ped (Abacavir and Lamivudine (pediatric))
    Mylan, India
  • Aspen Abacavir
    Aspen Pharmacare, South Africa
  • Cipla-Abacavir
    Cipla Medpro, South Africa
  • Epzicom (Abacavir and Lamivudine)
    GlaxoSmithKline, Russian Federation
  • Filabac
    Filaxis, Argentina
  • Kivexa (Abacavir and Lamivudine)
    Glaxo Group, Slovenia; GlaxoSmithKline, Chile; GlaxoSmithKline, Latvia; GlaxoSmithKline, Malaysia; ViiV Healthcare, Austria; ViiV Healthcare, Greece
  • Panka
    Microsules Arg, Argentina
  • Profelvir (Abacavir and Lamivudine)
    LKM, Argentina
  • Selmivir (Abacavir and Lamivudine)
    Richmond, Argentina
  • Triumeq (Abacavir and Dolutegravir, +Lamivudine)
    ViiV Healthcare, Germany; ViiV Healthcare, United Kingdom
  • Trivudin (Abacavir and Lamivudine, Zidovudine)
    Richmond, Argentina
  • Trizivir (Abacavir and Lamivudine, + Zidovudine)
    GlaxoSmithKline, China; GlaxoSmithKline, Ecuador; GlaxoSmithKline, Georgia; GlaxoSmithKline, Romania; GlaxoSmithKline, Taiwan; ViiV Healthcare, Italy; Viiv Healthcare S.L., Spain; Viivhiv, Portugal; GlaxoSmithKline, Peru
  • Zepril
    Richmond, Argentina
  • Ziagen
    Glaxo Wellcome, Tunisia; GlaxoSmithKline, Colombia; GlaxoSmithKline, Georgia; GlaxoSmithKline, Peru; GlaxoSmithKline, Russian Federation; GlaxoSmithKline, Taiwan; GlaxoSmithKline, South Africa; GlaxoSmithKline Inc., Russian Federation; GSK, Turkey; ViiV Healthcare, Tunisia; Viiv Healthcare S.L., Spain
  • Abac
    Ranbaxy Laboratories LTD, Kenya
  • Abamune Trio (Abacavir and Zidovudine, + Lamivudine)
    Biotoscana, Colombia
  • Epzicom (Abacavir and Lamivudine)
    GlaxoSmithKline, United States; ViiV Healthcare, Japan
  • Finecil
    LKM, Argentina
  • Kivexa (Abacavir and Lamivudine)
    Glaxo Wellcome, Serbia; GlaxoSmithKline, Argentina; GlaxoSmithKline, Colombia; GlaxoSmithKline, Denmark; GlaxoSmithKline, Ecuador; GlaxoSmithKline, Hong Kong; GlaxoSmithKline, Croatia (Hrvatska); GlaxoSmithKline, Israel; GlaxoSmithKline, Mexico; GlaxoSmithKline, New Zealand; GlaxoSmithKline, Romania; GlaxoSmithKline, Sweden; GlaxoSmithKline, Singapore; GlaxoSmithKline, Thailand; GlaxoSmithKline, Taiwan; GlaxoSmithKline, South Africa; ViiV, Australia; ViiV, Belgium; ViiV, Hungary; ViiV, Netherlands; ViiV Healthcare, Switzerland; ViiV Healthcare, Czech Republic; ViiV Healthcare, Germany; ViiV Healthcare, France; ViiV Healthcare, United Kingdom; ViiV Healthcare, Ireland; ViiV Healthcare, Italy; ViiV Healthcare, Lithuania; ViiV Healthcare, Norway; Viiv Healthcare S.L., Spain; ViiV Healthcare UK Limited, Iceland; ViiV Healthcare ULC, Canada; Viivhiv, Portugal
  • Lamcavir (Abacavir and Lamivudine)
    Humax Pharmaceutical, Colombia
  • Lamivudina + Zidovudina + Abacavir (Abacavir and Lamivudine, + Zidovudine)
    Humax Pharmaceutical, Colombia
  • Plusabcir
    Dosa, Argentina
  • Tivizid (Abacavir and Lamivudine + Zidovudine)
    Square, Bangladesh
  • Tricivir (Abacavir and Lamivudine, Zidovudine)
    GlaxoSmithKline, Argentina
  • Trilaxis (Abacavir and Lamivudine, Zidovudine)
    Filaxis, Argentina
  • Triumeq (Abacavir and Dolutegravir, +Lamivudine)
    ViiV Healthcare, Switzerland; ViiV Healthcare, United States; ViiV Healthcare ULC, Canada
  • Trizivir (Abacavir and Lamivudine, + Zidovudine)
    Glaxo Wellcome, Serbia; GlaxoSmithKline, Belgium; GlaxoSmithKline, Colombia; GlaxoSmithKline, Denmark; GlaxoSmithKline, Greece; GlaxoSmithKline, Hong Kong; GlaxoSmithKline, Israel; GlaxoSmithKline, Lithuania; GlaxoSmithKline, Oman; GlaxoSmithKline, Sweden; GlaxoSmithKline, United States; GlaxoSmithKline, South Africa; ViiV, Australia; ViiV, Netherlands; ViiV Healthcare, Austria; ViiV Healthcare, Switzerland; ViiV Healthcare, Czech Republic; ViiV Healthcare, Germany; ViiV Healthcare, France; ViiV Healthcare, United Kingdom; ViiV Healthcare, Ireland; ViiV Healthcare, Norway; ViiV Healthcare UK Limited, Iceland; ViiV Healthcare ULC, Canada
  • Ziagen
    Glaxo Group, Lithuania; Glaxo Wellcome, Slovenia; GlaxoSmithKline, Chile; GlaxoSmithKline, China; GlaxoSmithKline, Denmark; GlaxoSmithKline, Greece; GlaxoSmithKline, Hong Kong; GlaxoSmithKline, Croatia (Hrvatska); GlaxoSmithKline, Israel; GlaxoSmithKline, Japan; GlaxoSmithKline, Malaysia; GlaxoSmithKline, New Zealand; GlaxoSmithKline, Oman; GlaxoSmithKline, Romania; GlaxoSmithKline, Serbia; GlaxoSmithKline, Sweden; GlaxoSmithKline, Slovakia; GlaxoSmithKline, United States; ViiV, Belgium; ViiV, Hungary; ViiV, Netherlands; ViiV Healthcare, Austria; ViiV Healthcare, Switzerland; ViiV Healthcare, Czech Republic; ViiV Healthcare, Germany; ViiV Healthcare, France; ViiV Healthcare, United Kingdom; ViiV Healthcare, Ireland; ViiV Healthcare, Italy; ViiV Healthcare, Norway; ViiV Healthcare UK Limited, Iceland; ViiV Healthcare ULC, Canada; Viivhiv, Portugal
  • Ziagenavir
    GlaxoSmithKline, Argentina; GlaxoSmithKline, Brazil; GlaxoSmithKline, Thailand
  • Zidomuv (Abacavir and Lamivudine, Zidovudine)
    LKM, Argentina

International Drug Name Search

Glossary

TermDefinition
BANBritish Approved Name
BANMBritish Approved Name (Modified)
DCFDénomination Commune Française
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide